Skip to main content
. Author manuscript; available in PMC: 2019 Jul 24.
Published in final edited form as: Br J Haematol. 2017 Oct 29;179(5):739–747. doi: 10.1111/bjh.14951

Table III:

Evaluation of End-of-therapy FDG-PET

Disease Status
Relapsed
(n)
Not relapsed
(n)
Percentage
PET + (Deauville 4–5) 13 18
PET – (Deauville 1–3) 4 90
Total 17 108
Sensitivity 76.5
Specificity 83.3
Positive predictive value 41.9
Negative predictive value 95.7

Calculations are based on data from 125 patients with available Deauville scoring for end-of-therapy fluorodeoxyglucose positron emission tomography (FDG-PET).